Antibe Therapeutics Inc.

(ATE:CA)

By |

Profile

Antibe Therapeutics Inc is a human drug development company. It is engaged in the development of patents and out-licensing of improved compounds of existing drugs. Its product includes ATB-346 a hydrogen sulfide-releasing derivative of naproxen.

Contact Information

Website: www.antibethera.com
Main Phone: +1 905 726-0995
Address: 15 Prince Arthur Avenue
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5R 1B2

Issuer Information

Exchange: CDX
NAICS: Pharmaceutical P
$ 0.08 $ -0.005 (-5.88%)
Last Price 0.08 Change $ -0.005 Change % -5.88 Tick N/A
Bid 0.09 Bid Size 2,000.00 Ask 0.09 Ask Size 298,000.00
Open N/A High N/A Low N/A Prev Close 0.085
Last Trade Volume 65,300 52 Wk Hi 0.29 52 Wk Low 0.08
Market Cap 12.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 153,637,313.00 EPS (TTM) -0.06 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.4 0.4 0.4 0.4
Low Target Price Estimate 0.4 0.4 0.4 0.4
Mean Target Price Estimate 0.4 0.4 0.4 0.4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/11/16 04/11/16 04/11/16 04/11/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1